4 Year Extension Study of Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Chronic Plaque-type Psoriasis
Clinical trial NCT01640951 · COMPLETED
Trial details
- NCT number
- NCT01640951
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-16
- Primary completion
- 2017-05-04
- Enrollment
- 675
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.